Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | International Journal of Neuropsychopharmacology | journal | 2.121 Q1 | 125 | 202 | 368 | 11376 | 1818 | 354 | 4.52 | 56.32 | 37.92 | |
2 | PharmacoEconomics | journal | 1.713 Q1 | 118 | 98 | 282 | 4577 | 995 | 240 | 3.47 | 46.70 | 42.06 | |
3 | Cancer Biology and Therapy | journal | 1.631 Q1 | 130 | 152 | 761 | 6224 | 2813 | 645 | 3.69 | 40.95 | 41.52 | |
4 | CNS Neuroscience and Therapeutics | journal | 1.603 Q1 | 91 | 151 | 299 | 5770 | 1229 | 244 | 3.69 | 38.21 | 40.06 | |
5 | Expert Review of Vaccines | journal | 1.381 Q1 | 105 | 142 | 459 | 10084 | 1679 | 380 | 3.54 | 71.01 | 38.21 | |
6 | Frontiers in Pharmacology | journal | 1.352 Q1 | 154 | 150 | 335 | 11057 | 1197 | 329 | 3.70 | 73.71 | 43.46 | |
7 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.299 Q1 | 57 | 68 | 155 | 2448 | 479 | 150 | 3.48 | 36.00 | 30.69 | |
8 | Current Pharmaceutical Design | journal | 1.295 Q1 | 183 | 659 | 1399 | 71581 | 5281 | 1284 | 3.55 | 108.62 | 40.30 | |
9 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.252 Q1 | 47 | 19 | 36 | 835 | 96 | 35 | 2.67 | 43.95 | 42.98 | |
10 | Open Medicinal Chemistry Journal | journal | 1.227 Q1 | 23 | 7 | 23 | 247 | 102 | 21 | 4.35 | 35.29 | 43.59 | |
11 | Therapeutic Advances in Neurological Disorders | journal | 1.144 Q1 | 68 | 31 | 88 | 2319 | 397 | 86 | 4.82 | 74.81 | 48.65 | |
12 | Cancer Chemotherapy and Pharmacology | journal | 1.122 Q1 | 122 | 319 | 891 | 10237 | 2832 | 873 | 3.06 | 32.09 | 31.47 | |
13 | Cardiovascular Therapeutics | journal | 1.089 Q1 | 54 | 72 | 190 | 3141 | 609 | 178 | 2.95 | 43.63 | 26.62 | |
14 | Journal of Pharmacological Sciences | journal | 1.023 Q2 | 101 | 125 | 495 | 4588 | 1202 | 494 | 2.38 | 36.70 | 29.41 | |
15 | Journal of Physiology and Pharmacology | journal | 0.998 Q2 | 89 | 91 | 255 | 4325 | 769 | 254 | 3.01 | 47.53 | 44.69 | |
16 | Drug Design, Development and Therapy | journal | 0.979 Q2 | 94 | 146 | 114 | 7597 | 484 | 114 | 4.27 | 52.03 | 35.67 | |
17 | Chinese Medicine | journal | 0.885 Q2 | 56 | 23 | 112 | 955 | 390 | 105 | 3.11 | 41.52 | 35.05 | |
18 | Pharmacognosy Reviews (discontinued) | journal | 0.862 Q2 | 68 | 25 | 73 | 1805 | 281 | 72 | 3.45 | 72.20 | 21.33 | |
19 | Drug Metabolism and Pharmacokinetics | journal | 0.847 Q2 | 75 | 78 | 234 | 2830 | 676 | 206 | 3.14 | 36.28 | 29.90 | |
20 | Altex | journal | 0.841 Q2 | 64 | 39 | 102 | 2875 | 293 | 81 | 2.78 | 73.72 | 43.32 | |
21 | Pharmacological Reports | journal | 0.811 Q2 | 98 | 174 | 460 | 7961 | 1162 | 446 | 2.48 | 45.75 | 53.34 | |
22 | Antiviral Chemistry and Chemotherapy | journal | 0.801 Q2 | 59 | 7 | 63 | 451 | 175 | 61 | 2.40 | 64.43 | 20.00 | |
23 | Biomarker Insights | journal | 0.793 Q2 | 40 | 16 | 52 | 643 | 141 | 52 | 2.39 | 40.19 | 22.54 | |
24 | Biomedicine and Pharmacotherapy | journal | 0.769 Q2 | 149 | 119 | 324 | 4233 | 807 | 319 | 2.41 | 35.57 | 46.62 | |
25 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.701 Q2 | 64 | 51 | 71 | 2388 | 190 | 69 | 2.77 | 46.82 | 37.31 | |
26 | Core Evidence (discontinued) | journal | 0.685 Q2 | 29 | 7 | 29 | 442 | 82 | 28 | 3.63 | 63.14 | 15.79 | |
27 | Human Vaccines and Immunotherapeutics | journal | 0.676 Q2 | 93 | 403 | 318 | 14429 | 519 | 215 | 1.63 | 35.80 | 45.70 | |
28 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.645 Q2 | 92 | 168 | 342 | 5993 | 674 | 340 | 2.16 | 35.67 | 39.45 | |
29 | Journal of Toxicology | journal | 0.642 Q2 | 47 | 27 | 117 | 1349 | 284 | 113 | 2.55 | 49.96 | 39.20 | |
30 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.624 Q2 | 88 | 56 | 140 | 3727 | 381 | 140 | 2.28 | 66.55 | 39.22 | |
31 | Infection and Drug Resistance | journal | 0.601 Q2 | 65 | 27 | 47 | 1454 | 123 | 46 | 2.77 | 53.85 | 37.72 | |
32 | Pharmacogenomics and Personalized Medicine | journal | 0.572 Q2 | 37 | 16 | 33 | 996 | 73 | 33 | 2.68 | 62.25 | 55.17 | |
33 | Drugs in R and D | journal | 0.557 Q3 | 54 | 33 | 83 | 952 | 169 | 79 | 2.09 | 28.85 | 40.00 | |
34 | Pharmacognosy Research (discontinued) | journal | 0.540 Q3 | 44 | 51 | 167 | 1464 | 265 | 156 | 1.70 | 28.71 | 33.71 | |
35 | Korean Journal of Physiology and Pharmacology | journal | 0.526 Q3 | 40 | 75 | 190 | 3028 | 269 | 190 | 1.44 | 40.37 | 36.03 | |
36 | Records of Natural Products | journal | 0.509 Q3 | 41 | 55 | 137 | 1149 | 248 | 136 | 1.47 | 20.89 | 38.21 | |
37 | Pharmaceutical Biology | journal | 0.493 Q3 | 88 | 213 | 591 | 7772 | 1017 | 591 | 1.72 | 36.49 | 37.32 | |
38 | Acta Pharmaceutica | journal | 0.492 Q3 | 67 | 40 | 120 | 1332 | 241 | 120 | 1.54 | 33.30 | 42.95 | |
39 | International Journal of Pharmacy and Pharmaceutical Sciences (discontinued) | journal | 0.488 Q3 | 58 | 1091 | 1989 | 29240 | 2228 | 1988 | 0.99 | 26.80 | 42.25 | |
40 | Journal of Receptor, Ligand and Channel Research | journal | 0.481 Q3 | 13 | 2 | 12 | 279 | 23 | 11 | 0.43 | 139.50 | 33.33 | |
41 | Interdisciplinary Toxicology | journal | 0.451 Q3 | 38 | 33 | 93 | 1706 | 153 | 88 | 1.71 | 51.70 | 50.81 | |
42 | Natural Product Communications | journal | 0.412 Q3 | 63 | 457 | 1294 | 11133 | 1501 | 1268 | 1.10 | 24.36 | 39.95 | |
43 | Saudi Pharmaceutical Journal | journal | 0.410 Q3 | 76 | 52 | 114 | 1652 | 205 | 114 | 1.57 | 31.77 | 26.11 | |
44 | International Journal of Immunopathology and Pharmacology | journal | 0.395 Q3 | 65 | 133 | 542 | 3480 | 1019 | 527 | 1.92 | 26.17 | 52.34 | |
45 | Journal of Pharmacology and Pharmacotherapeutics | journal | 0.386 Q3 | 42 | 95 | 208 | 1770 | 201 | 110 | 0.84 | 18.63 | 43.58 | |
46 | International Journal of PharmTech Research (discontinued) | journal | 0.361 Q3 | 54 | 227 | 951 | 4933 | 878 | 951 | 0.76 | 21.73 | 35.61 | |
47 | Indian Journal of Pharmacology | journal | 0.360 Q3 | 68 | 173 | 516 | 2858 | 535 | 410 | 1.01 | 16.52 | 35.66 | |
48 | Acta Poloniae Pharmaceutica | journal | 0.358 Q3 | 52 | 128 | 410 | 3500 | 509 | 408 | 1.00 | 27.34 | 52.60 | |
49 | Drug, Healthcare and Patient Safety | journal | 0.347 Q3 | 30 | 25 | 58 | 765 | 84 | 57 | 1.64 | 30.60 | 35.94 | |
50 | DARU, Journal of Pharmaceutical Sciences | journal | 0.338 Q3 | 58 | 78 | 205 | 2079 | 289 | 193 | 1.35 | 26.65 | 32.86 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®